CPIX SEC Form 4 filings

Cumberland Pharmaceuticals Inc Latest Insider Trading Activity

Over the past 496 days, Cumberland Pharmaceuticals Inc (CPIX) has had 212 total open-market insider transactions represented in the displayed records. The latest displayed record by transaction date reports 21 purchases by Jones James (Cumberland Pharmaceuticals Inc Director) totaling 262 shares at a weighted-average price of $3.29 per share, with the latest transaction dated August 29, 2025. This page shows up to the 10 most recent SEC Form 4 filing records on a 6-hour delay. Sign up for real-time updates and access to 20 years of historic insider trading data.

Insider Trading For CPIX Charted on Daily Candles. Scroll left or zoom out to load earlier candles (up to 2 years).

▲ Insider buy ▼ Insider sale
Loading daily price history…
Charting by TradingView Lightweight Charts
Ticker Filing Date Transaction Date Company Insider Title Transaction Trade Count Shares Avg. Price Total Value Position Size Change SEC Filing
10b5-1: Scheduled Form 4 Transaction CPIX 2025-09-12 2025-08-29 Cumberland Pharmaceuticals Inc Jones James Director Buy 21 262 $3.29 $861.57 0.03% View Filing
10b5-1: Scheduled Form 4 Transaction CPIX 2025-09-12 2025-08-29 Cumberland Pharmaceuticals Inc Kazimi A J Chairman and CEO Buy 21 262 $3.29 $861.57 <0.01% View Filing
Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. CPIX 2025-08-11 2025-07-31 Cumberland Pharmaceuticals Inc Young Caroline Director Buy 22 168 $3.44 $577.90 0.02% View Filing
Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. CPIX 2025-08-11 2025-07-31 Cumberland Pharmaceuticals Inc Jones James Director Buy 22 340 $3.43 $1,166.13 0.04% View Filing
Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. CPIX 2025-08-11 2025-07-31 Cumberland Pharmaceuticals Inc Kazimi A J Chairman and CEO Buy 22 340 $3.43 $1,166.13 <0.01% View Filing
Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. CPIX 2025-08-11 2025-07-31 Cumberland Pharmaceuticals Inc Krogulski Kenneth Director Buy 22 1,712 $3.43 $5,872.20 0.03% View Filing
10b5-1: Scheduled Form 4 Transaction CPIX 2025-07-11 2025-06-30 Cumberland Pharmaceuticals Inc Young Caroline Director Buy 20 84 $4.80 $403.60 0.01% View Filing
10b5-1: Scheduled Form 4 Transaction CPIX 2025-07-11 2025-06-30 Cumberland Pharmaceuticals Inc Krogulski Kenneth Director Buy 20 935 $4.83 $4,513.10 0.02% View Filing
10b5-1: Scheduled Form 4 Transaction CPIX 2025-06-06 2025-05-30 Cumberland Pharmaceuticals Inc Krogulski Kenneth Director Buy 21 945 $5.11 $4,824.45 0.02% View Filing
10b5-1: Scheduled Form 4 Transaction CPIX 2025-05-09 2025-04-30 Cumberland Pharmaceuticals Inc Young Caroline Director Buy 21 93 $4.48 $416.65 0.01% View Filing

Pricing

Free Trial

10 trading days
$0

Explore every Premium feature before you pay.

  • Full platform access
  • 10 trading days
  • No credit card required
  • 20 years of alert history
  • Live alert directory updates
Start your free trial

Standard Monthly

Scheduled
$19.99 / month

Scheduled alerts with complete trade context.

  • Email and Telegram delivery
  • Alert intervals from every sixty minutes to once daily
  • Filter by insider title, buy/sell, transaction value, DRIP, ESPP, 10b5-1, and tax liability coverage transfers
  • Highlighted cluster transactions and SEC filing links
  • Access to the alert directory hourly refreshes
Choose Standard Monthly

Premium Monthly

Recommended
$29.99 / month

Fastest alerts with ticker-level control.

  • Everything in Standard
  • Instant delivery detection-to-outbound time averages 3.00 seconds
  • Alert intervals starting from one minute
  • Real time alert directory updates
Choose Premium Monthly
Student discount: Customers who sign up with a verified .edu email address receive 50% off for the first four years. On monthly plans, the first month is the full 75% off.
Alerts are based on public SEC filings and are provided for informational purposes only; they do not constitute financial advice.